Free Trial
Your Rate Never Goes Up! Save $100 a Year on MarketBeat All Access
Upgrade Now
Claim MarketBeat All Access Sale Promotion

45,118 The Clorox Company $CLX Shares Bought by Nisa Investment Advisors LLC

Clorox logo with Consumer Staples background
Image from MarketBeat Media, LLC.

Key Points

  • Nisa Investment Advisors increased its Clorox stake by 167% in the third quarter, purchasing 45,118 additional shares and bringing its holdings to 72,129 shares valued at approximately $5.84 million. Institutional investors collectively own 78.53% of Clorox.
  • Analysts remain cautious on Clorox, with 12 Hold ratings and four Sell ratings; its average rating is “Reduce” and the average price target is $93.57 after several firms lowered targets.
  • Clorox reported quarterly earnings and revenue slightly above expectations, but revenue declined 2% year over year. The company declared a $1.25 quarterly dividend, equal to a 5.8% annualized yield, though its payout ratio exceeds 100%.
  • Get every upgrade, downgrade, and earnings report on Clorox as it happens. Lock in MarketBeat All Access for $149 a year through October 30.

Nisa Investment Advisors LLC increased its position in The Clorox Company (NYSE:CLX - Free Report) by 167.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 72,129 shares of the company's stock after buying an additional 45,118 shares during the quarter. Nisa Investment Advisors LLC owned about 0.06% of Clorox worth $5,843,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently modified their holdings of the company. Ancora Advisors LLC purchased a new stake in Clorox during the 2nd quarter worth $28,000. Avalon Trust Co purchased a new position in shares of Clorox during the 2nd quarter valued at approximately $29,000. Markowski Investments acquired a new position in Clorox in the second quarter worth about $30,000. Root Financial Partners LLC increased its holdings in shares of Clorox by 83.8% in the 1st quarter. Root Financial Partners LLC now owns 318 shares of the company's stock valued at $33,000 after acquiring an additional 145 shares during the last quarter. Finally, Pension & Wealth Management Advisors Inc. bought a new stake in Clorox during the third quarter valued at $26,000. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on CLX shares. TD Cowen cut their price target on Clorox from $85.00 to $80.00 and set a "hold" rating on the stock in a report on Tuesday, October 13th. Citigroup cut their target price on Clorox from $97.00 to $90.00 and set a "neutral" rating on the stock in a research note on Wednesday, October 14th. Barclays reduced their price target on shares of Clorox from $84.00 to $80.00 and set an "underweight" rating for the company in a report on Friday, October 16th. Wells Fargo & Company lowered their price target on shares of Clorox from $90.00 to $85.00 and set an "equal weight" rating for the company in a research report on Monday, October 5th. Finally, Zacks Research raised shares of Clorox from a "strong sell" rating to a "hold" rating in a report on Monday, September 14th. Twelve equities research analysts have rated the stock with a Hold rating and four have given a Sell rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Reduce" and an average target price of $93.57.

Get Our Latest Stock Analysis on Clorox

Clorox Price Performance

NYSE:CLX opened at $86.38 on Friday. The business's 50-day moving average price is $90.24 and its 200 day moving average price is $94.73. The firm has a market cap of $10.45 billion, a P/E ratio of 17.92, a PEG ratio of 2.95 and a beta of 0.59. The Clorox Company has a 52-week low of $79.12 and a 52-week high of $128.90. The company has a quick ratio of 0.38, a current ratio of 0.66 and a debt-to-equity ratio of 15.80.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Monday, August 3rd. The company reported $1.66 earnings per share for the quarter, topping analysts' consensus estimates of $1.64 by $0.02. The firm had revenue of $1.95 billion during the quarter, compared to analysts' expectations of $1.91 billion. Clorox had a net margin of 8.74% and a return on equity of 522.23%. The firm's revenue for the quarter was down 2.0% compared to the same quarter last year. During the same period last year, the firm posted $2.87 earnings per share. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. As a group, sell-side analysts predict that The Clorox Company will post 5.70 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Wednesday, October 28th will be given a dividend of $1.25 per share. The ex-dividend date is Wednesday, October 28th. This represents a $5.00 dividend on an annualized basis and a yield of 5.8%. Clorox's dividend payout ratio (DPR) is presently 103.73%.

About Clorox

(Free Report)

The Clorox Company, founded in 1913 and headquartered in Oakland, California, is a consumer and professional products company. It began with household bleach and has expanded into a portfolio of brands serving cleaning, household, personal care, food, and professional markets.

Its brands include Clorox disinfecting and cleaning products, Pine-Sol cleaners, Liquid-Plumr drain care, Kingsford charcoal, Fresh Step and Scoop Away cat litter, Hidden Valley dressings and dips, Brita water filtration products, and Burt's Bees personal care items.

Featured Stories

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines